# Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)

> **NCT00630500** · PHASE2 · COMPLETED · sponsor: **Helse Stavanger HF** · enrollment: 75 (actual)

## Conditions studied

- Dementia Associated With Parkinson's Disease
- Dementia With Lewy Bodies

## Interventions

- **DRUG:** Memantine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00630500
- **Lead sponsor:** Helse Stavanger HF
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2009-02
- **Final completion:** 2009-03
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2015-07-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00630500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00630500, "Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00630500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*